A Review of Progress in Clinical Photodynamic Therapy

Technology in Cancer Research and Treatment - Tập 4 Số 3 - Trang 283-293 - 2005
Zheng Huang1
1HealthONE Alliance 899 Logan Street, Suite 203 Denver, CO 80203, USA

Tóm tắt

Photodynamic therapy (PDT) has received increased attention since the regulatory approvals have been granted to several photosensitizing drugs and light applicators worldwide. Much progress has been seen in basic sciences and clinical photodynamics in recent years. This review will focus on new developments of clinical investigation and discuss the usefulness of various forms of PDT techniques for curative or palliative treatment of malignant and non-malignant diseases.

Từ khóa


Tài liệu tham khảo

10.1016/S0022-5223(19)32560-7

Dougherty T. J., Henderson B. W., Schwartz S., Winkelman J. W., Lipson R. L. In Historical Perspective in Photodynamic Therapy, pp. 1–18, Eds. Henderson B. W. and Dougherty T. J. Maurice Dekker, New York (1992).

10.1093/jnci/55.1.115

Dougherty T. J., 1978, Cancer Res., 38, 2628

Dougherty T. J., 1979, J. Natl. Cancer Inst., 62, 231

10.1093/jnci/90.12.889

10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO;2

10.1517/14656566.2.6.917

Gudgin Dickson E. F., 2002, Cell. Mol. Biol., 48, 939

Almeida R. D., 2004, Biochim. Biophys. Acta, 1704, 59

10.1016/S1470-2045(04)01529-3

10.1007/3-540-26809-X_12

Castano A. P., Nemidova T. N., Hamblin M. R. Mechanisms in Photodynamic Therapy: Part I – Photosensitizers, Photochemistry and Cellular Location. Photodiag. Photodyn. Therapy (in press) (2005).

Castano A. P., Nemidova T. N., Hamblin M. R. Mechanisms in Photodynamic Therapy: Part II – Cellular Signaling, Cell Metabolism and Modes of Cell Death. Photodiag. Photodyn. Therapy (in press) (2005).

Moser J. G., 1997, Photodynamic Tumor Therapy - 2nd & 3rd Generation Photosensitizers, 3

10.1016/S1572-1000(04)00007-9

10.1021/jm040074b

Schmidt M. H., 1996, Neurosurgery, 38, 552

10.1002/cncr.11708

10.1097/00130404-200203000-00009

10.1007/s10103-004-0314-x

10.1016/S1572-1000(04)00012-2

10.1038/bjc.1993.259

10.1016/1011-1344(92)85108-7

10.1016/S1011-1344(97)00096-1

10.2165/00128071-200001020-00009

10.1080/000155599750009898

10.1016/S0140-6736(00)90013-8

10.1046/j.1523-1747.2000.00046.x

10.1046/j.1365-2230.1999.00441.x

10.1038/bjc.1994.112

10.1111/j.1365-2133.1997.tb03944.x

Morton C. A., 2001, Arch. Dermatol., 137, 319

10.1046/j.1365-2230.2002.01119.x

10.1046/j.1365-2133.2003.05360.x

10.1016/S0190-9622(03)00868-5

Gold M. H., 2004, J. Drugs Dermatol., 3, S6

10.1001/archderm.141.1.60

10.1016/S1011-1344(96)07377-0

Hunt D. W., 2002, IDrugs, 5, 180

10.1200/JCO.1987.5.11.1766

10.1016/0360-3016(91)90793-4

10.1002/ijc.1400

10.1016/S0896-1549(02)00044-5

10.2165/00003495-200363220-00016

10.1097/00006982-200408000-00003

10.1136/bjo.2004.044396

10.1097/00005537-199809000-00001

10.1016/S1011-1344(96)07366-6

10.1177/153303460300200405

10.1002/hed.10372

10.1001/archotol.129.7.709

10.1002/ssu.2980110504

10.1002/1096-9101(2000)27:3<224::AID-LSM4>3.0.CO;2-#

10.1097/01376517-200112000-00003

10.1562/0031-8655(2001)074<0611:MMPDOM>2.0.CO;2

10.1177/153303460300200404

10.1002/lsm.10131

10.1016/j.jocn.2004.02.001

Stummer W., 2003, Acta Neurochir. Suppl., 88, 9

Friesen S. A., 2002, Int. J. Oncol., 21, 577

10.1562/2004-03-05-RA-100.1

10.1023/B:NEON.0000021804.50002.85

10.1080/026886900417298

10.1016/S0022-5223(19)38600-3

10.1002/lsm.1900060308

10.1378/chest.123.1_suppl.176S

10.1016/S1572-1000(04)00008-0

10.1002/(SICI)1096-9101(1999)24:3<194::AID-LSM4>3.0.CO;2-#

10.1016/j.lungcan.2003.08.016

10.1016/S0169-5002(03)00242-3

10.1097/01.mcp.0000128434.57020.6a

10.1007/BF02303746

10.1016/S0003-4975(98)00799-1

10.1378/chest.120.4.1167

10.1378/chest.122.5.1866

10.1007/s11864-001-0042-4

10.1562/0031-8655(2002)076<0197:IOTRBM>2.0.CO;2

10.1562/0031-8655(2003)078<0496:HETTCK>2.0.CO;2

10.1016/S1572-1000(04)00009-2

10.1089/clm.1996.14.343

10.1161/01.CIR.102.19.2322

10.1161/01.CIR.0000087602.91755.19

10.1016/j.jphotobiol.2003.10.004

10.1136/gut.43.3.345

10.1055/s-2004-828894

10.1001/archsurg.139.3.259

10.2174/1389201043376805

10.1016/S1052-5157(03)00049-7

10.1016/S0016-5107(04)02394-6

10.1016/S1572-1000(04)00013-4

10.1016/j.gastro.2003.07.015

10.1111/j.1440-1746.2005.03582.x

10.1016/S0016-5107(04)01288-X

10.1002/cncr.11401

10.1007/s00535-004-1449-z

10.1007/s00330-004-2290-8

10.1385/IJGC:35:1:001

10.1136/gut.50.4.549

10.1016/S0090-4295(97)00211-2

10.1016/S0022-5347(01)63021-0

10.1089/089277903322518644

10.1093/jnci/94.23.1740

10.1046/j.1464-410X.1996.09717.x

10.1016/S0090-4295(02)02123-4

10.1016/S0022-5347(05)66239-8

10.1016/S0090-4295(02)02164-7

10.1046/j.1464-410X.2002.02743.x

10.1111/j.1751-1097.1993.tb04937.x

10.1007/s11934-003-0073-4

10.1016/S0022-5347(05)64466-7

10.1078/1615-1615-00092

10.1117/12.529181

10.1016/S1569-9056(04)90831-7

10.1097/01.ju.0000135304.96496.20

10.1562/2004-06-25-RA-216.1

10.1016/S1572-1000(04)00037-7

Weersink R. A., Bogaards A., Gertner M., Davidson S. R. H., Zhang K., Netchev G., Trachtenberg T., Wilson B. C. Techniques for Delivery and Monitoring of TOOKAD (WST09)-mediated Photodynamic Therapy of the Prostate: Clinical Experience and Practicalities. Photochem. Photobiol. Sci. (in press) (2005).

10.1089/pho.2005.23.172

10.1667/RR3186

10.1562/0031-8655(2002)076<0438:PSINCP>2.0.CO;2

Huang Z., Chen Q., Luck D., Beckers J., Wilson B. C., Trncic N., LaRue S. M., Blanc D., Hetzel F. W. Studies of a Vascular-acting Photosensitizer, Pd-bacteriopheophorbide (Tookad), in Normal Canine Prostate and Spontaneous Canine Prostate Cancer. Lasers Surg. Med. (in press) (2005).

10.1016/S0022-5347(17)32337-6

Muroya T., 1996, Gan To Kagaku Ryoho, 23, 47

10.1006/gyno.1996.4463

10.1002/(SICI)1097-0215(19990331)81:1<34::AID-IJC7>3.0.CO;2-H

10.1002/lsm.10111

10.1002/ijc.10888

Chen W. R., Huang Z., Korbelik M., Nordquist R. E., Liu H. Photoimmunotherapy for Cancer Treatment. J. Environ. Pathol. Toxicol. Oncol. (in press) (2005).